Kolexia
Berceanu Ana Hématologie
Berceanu Ana
Hématologie
Hôpital Jean-Minjoz
Besançon, France
121 Activités
0 Followers
Scientifique
Digital
Production scientifique
Activités par an
Expertise
Sujets de recherche
{{person.topmesh1.name}} Leucémies Leucémie aigüe myéloïde Leucémie myéloïde Maladie du greffon contre l'hôte Tumeurs hématologiques Leucémie-lymphome lymphoblastique à précurseurs B et T Aspergillose COVID-19 Mucormycose

Collaborateurs

Voir plus
Chevallier Patrice
Chevallier Patrice
Hôpital Hôtel-Dieu Nantes, Nantes, France
Daguindau Etienne
Daguindau Etienne
Hôpital Jean-Minjoz, Besançon, France
Nguyen-Quoc Stephanie
Nguyen-Quoc Stephanie
Hôpital Pitie Salpetriere, Paris, France
Huynh-Finkeltin Anne
Huynh-Finkeltin Anne
Institut Universitaire du Cancer Toulouse Oncopole, Toulouse, France

Industries

Voir plus
Novartis
3 collaboration(s)
Dernière en 2021
A+A
2 collaboration(s)
Dernière en 2020
Servier
2 collaboration(s)
Dernière en 2021
Pfizer
2 collaboration(s)
Dernière en 2022

Dernières activités

Voir plus
Efficacy and safety of Daratumumab for the treatment of ABO-incompatible pure red cell aplasia after allogenic HSCT: report from SFGM-TC.
Bone marrow transplantation   09 mars 2024
National Acute Promyelocytic Leukemia (APL) Observational Study NAPOLEON-Registry of the German AML Intergroup
Essai Clinique (Gesellschaft fur Medizinische Innovation - Hamatologie und Onkologie mbH)   22 février 2024
Kidney transplantation after allogeneic Hematopoietic cell transplantation
Kidney international reports   30 janvier 2024
HAPLO-EMPTY: Haploidentical Allogeneic Hematopoietic Stem Cell Transplantation With Post-transplant Cyclophosphamide in Patients With Acquired Refractory Aplastic Anemia or in Relapse After Immunosuppression: a Nationwide Phase II Study
Essai Clinique (Assistance publique – Hôpitaux de Paris)   21 novembre 2023
FLUCLORIC: Randomized Multicentric Phase III Study Comparing the Efficacy of 2 Reduced Intensity Conditioning Regimens (Clofarabine/Busulfan vs Fludarabine/Busulfan) in Adults With AML and Eligible to Allogeneic Stem Cell Transplantation
Essai Clinique (CHU Nantes)   13 novembre 2023
Efficacy and Tolerance of Brexucabtagene Autoleucel in Adults with Relapsed/Refractory B-Cell Precursor Acute Lymphoblastic Leukemia : A Graall Study from the Descar-T Registry
65th ASH Annual Meeting Abstracts   02 novembre 2023
Allogeneic Hematopoietic Cell Transplantation in the Elderly Results in Similar Survival with Matched Related or Unrelated and Haploidentical Donors: A Report from the Société Francophone De Greffe De Moelle Et De Thérapie Cellulaire (SFGM-TC)
65th ASH Annual Meeting Abstracts   02 novembre 2023
FLT3 Ligand Kinetic Profile Predicts Response to Treatment and Event-Free Survival (EFS) in Adults with High-Risk MDS/CMML Receiving CPX-351: A GFM Study
65th ASH Annual Meeting Abstracts   02 novembre 2023
Frontline Consolidation with Nelarabine for Adults with High-Risk T-Cell Acute Lymphoblastic Leukemia. Results of the Graall-2014/T Atriall Phase 2 Study
65th ASH Annual Meeting Abstracts   02 novembre 2023
IDUNN: A Randomised, Open-label, Multicentre, Phase 3 Trial of First-line Treatment With Mesenchymal Stromal Cells MC0518 Versus Best Available Therapy in Adult and Adolescent Subjects With Steroid-refractory Acute Graft-versus-host Disease After Allogeneic Haematopoietic Stem Cell Transplantation (IDUNN Trial)
Essai Clinique (medac GmbH)   02 novembre 2023